CLYM compared with SION: revenue, margins and what each company keeps, and the suppliers and customers both name

CLYMClimb Bio, Inc.

Mkt capRevenueRevenue

SIONSionna Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CLYMClimb Bio, Inc.

SIONSionna Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CLYM 5

—Acelyrinunlistedsupplier

—CRHunlistedsupplier

—Mabworksunlistedsupplier

—ProBioGen AG (ProBioGen)unlistedsupplier

1 more · CLYM chain ›

Shared 0

No shared counterparties.

Only SION 4

ABBVAbbVie Global Enterprises Ltd. ("AbbVie")supplier

SNYSanofi SA ("Sanofi")supplier

—Galapagosunlistedsupplier

—Cystic Fibrosis Foundation (CFF)

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedsupplier

CLYMClimb Bio, Inc.

8.87▼−4.93%· post 8.64

Mkt cap$521.0M

SIONSionna Therapeutics, Inc.

3.27▼−12.24%· post 3.31

ClosedNov 5 '26

Mkt cap$168.4M

Compare

ClosedNov 5 '26

CLYMClimb Bio, Inc.

SIONSionna Therapeutics, Inc.

8.87▼−4.93%post 8.64

Price

3.27▼−12.24%post 3.31

$521.0M

Mkt cap

$168.4M

CLYM8.87▼−4.93%vsSION3.27▼−12.24%ClosedNov 5 '26